ProPhase Labs Inc (PRPH)
5.57
+0.15
(+2.77%)
USD |
NASDAQ |
May 06, 13:40
ProPhase Labs SG&A Expense (Quarterly): 8.022M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 8.022M |
September 30, 2023 | 8.245M |
June 30, 2023 | 9.937M |
March 31, 2023 | 8.298M |
December 31, 2022 | 12.74M |
September 30, 2022 | 7.512M |
June 30, 2022 | 6.306M |
March 31, 2022 | 7.824M |
December 31, 2021 | 7.78M |
September 30, 2021 | 5.938M |
June 30, 2021 | 4.993M |
March 31, 2021 | 3.782M |
December 31, 2020 | 3.623M |
September 30, 2020 | 1.552M |
June 30, 2020 | 1.155M |
March 31, 2020 | 1.168M |
December 31, 2019 | 1.38M |
September 30, 2019 | 1.238M |
June 30, 2019 | 1.434M |
March 31, 2019 | 1.47M |
December 31, 2018 | 1.668M |
September 30, 2018 | 1.524M |
June 30, 2018 | 1.435M |
March 31, 2018 | 1.391M |
December 31, 2017 | 1.511M |
Date | Value |
---|---|
September 30, 2017 | 1.274M |
June 30, 2017 | 1.527M |
March 31, 2017 | 1.195M |
December 31, 2016 | 0.866M |
September 30, 2016 | 0.887M |
June 30, 2016 | 1.179M |
March 31, 2016 | 1.501M |
December 31, 2015 | -6.485M |
September 30, 2015 | 1.921M |
June 30, 2015 | 2.301M |
March 31, 2015 | 4.833M |
December 31, 2014 | 6.156M |
September 30, 2014 | 2.792M |
June 30, 2014 | 3.656M |
March 31, 2014 | 4.504M |
December 31, 2013 | 5.747M |
September 30, 2013 | 2.397M |
June 30, 2013 | 2.43M |
March 31, 2013 | 4.858M |
December 31, 2012 | 6.014M |
September 30, 2012 | 2.161M |
June 30, 2012 | 2.228M |
March 31, 2012 | 4.669M |
December 31, 2011 | 6.139M |
September 30, 2011 | 2.292M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.155M
Minimum
Jun 2020
12.74M
Maximum
Dec 2022
5.417M
Average
5.938M
Median
Sep 2021
SG&A Expense (Quarterly) Benchmarks
Fonar Corp | 5.587M |
XWELL Inc | 6.392M |
Applied DNA Sciences Inc | 3.084M |
Veracyte Inc | 48.21M |
OncoCyte Corp | 2.391M |